Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Recruiting
N/A
Interventional Study
Central Line Associated Blood Stream Infections (CLABSI)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 17,800 (estimated)
- Sponsor
- Swedish Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prospective, multi-center, cluster-randomized trial of a hospital Infection Preventionist (IP)-led quality improvement study to provide clinical teams with just-in-time clinical education and reinforcement of existing best practices recommendations based on the output of a possible Central Line Associated Blood Stream Infection (CLABSI) Machine Learning (ML) prediction model.
The objective is to …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The top twenty Providence St. Joseph Health Hospitals by CLABSI burden.
Exclusion Criteria:
* Less than 18 years of age
Contacts